GTF2E2

Transcription initiation factor IIE subunit beta · P29084 · GTF2E2 on Sugi Atlas →

0 patent compounds predicted against GTF2E2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GTF2E2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Evaluation of the Predictive Effect of Inflammatory Markers in MI Patients nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Studies on the Adaptive Responses to Hypoxia nanCOMPLETED
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Spironolactone and XPB-1 Integrity in the TFIIH Complex nanENROLLING_BY_INVITATION
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Molecular Mechanism of Nasopharyngeal Carcinoma nanUNKNOWN
Gene Expression and Inflammation in Overweight Subjects nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a GTF2E2 binder may also engage these)

ProteinNameSimilarity
Q9D902 1.000 Q9D902 →
P29540 1.000 P29540 →
Q2KJF9 1.000 Q2KJF9 →
Q5ZJ85 0.979 Q5ZJ85 →
Q9DBA9 0.977 Q9DBA9 →
A2VDN6 0.976 A2VDN6 →
Q9CZT4 0.976 Q9CZT4 →
Q7TNE3 0.976 Q7TNE3 →
A1A4I9 0.976 A1A4I9 →
Q922U1 0.975 Q922U1 →
Q9JKB8 0.974 Q9JKB8 →
Q4R367 0.974 Q4R367 →
PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 0.974 landscape →
Q2KIA6 0.974 Q2KIA6 →
P32780 0.973 P32780 →
Q9XHM1 0.973 Q9XHM1 →
Q5R5F1 0.972 Q5R5F1 →
Q4R8N2 0.972 Q4R8N2 →
Q6QD73 0.972 Q6QD73 →
Q6DDM4 0.971 Q6DDM4 →
Q9QXN3 0.971 Q9QXN3 →
Q8CCJ3 0.971 Q8CCJ3 →
O43513 0.970 O43513 →
O75391 0.970 O75391 →
A2VD00 0.970 A2VD00 →
Q5ZMW3 0.970 Q5ZMW3 →
Q9R1C0 0.970 Q9R1C0 →
Q9NVU0 0.970 Q9NVU0 →
Q5R6F1 0.970 Q5R6F1 →
Q5JSJ4 0.970 Q5JSJ4 →